Back to top
more

Incyte (INCY)

(Real Time Quote from BATS)

$52.39 USD

52.39
461,133

-0.43 (-0.81%)

Updated Apr 19, 2024 11:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for INCY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Incyte Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 3,656 3,239 2,348 1,801 2,118
Receivables 744 645 616 482 309
Notes Receivable NA 0 0 0 0
Inventories 63 42 28 16 11
Other Current Assets 183 167 126 60 44
Total Current Assets 4,645 4,093 3,119 2,360 2,481
Net Property & Equipment 752 739 724 560 378
Investments & Advances 188 134 221 222 134
Other Non-Current Assets 207 79 29 20 5
Deferred Charges 632 458 468 0 0
Intangibles 279 285 306 328 349
Deposits & Other Assets 54 27 39 43 50
Total Assets 6,782 5,841 4,933 3,561 3,427
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 0 0 0 0
Accounts Payable 110 278 172 99 84
Current Portion Long-Term Debt NA 0 0 0 18
Current Portion Capital Leases 3 3 3 2 1
Accrued Expenses 1,127 876 680 530 411
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities 1,240 1,157 854 631 513
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases 29 30 32 33 32
Other Non-Current Liabilities 323 284 277 286 283
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 1,592 1,471 1,163 950 828
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 5,016 4,792 4,567 4,353 4,044
Retained Earnings 160 -437 -778 -1,726 -1,431
Other Equity 13 15 -19 -15 -16
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 5,190 4,370 3,770 2,611 2,598
Total Liabilities & Shareholder's Equity 6,782 5,841 4,933 3,561 3,427
Total Common Equity 105,189 4,370 3,770 2,611 2,598
Shares Outstanding 224.10 222.40 220.80 219.00 215.40
Book Value Per Share 469.38 19.65 17.07 11.92 12.06

Fiscal Year End for Incyte Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 3,656 3,516 3,423 3,113
Receivables NA 744 657 638 624
Notes Receivable NA NA 0 0 0
Inventories NA 63 57 36 41
Other Current Assets NA 183 172 167 194
Total Current Assets NA 4,645 4,403 4,264 3,972
Net Property & Equipment NA 752 733 749 742
Investments & Advances NA 188 154 170 128
Other Non-Current Assets NA 207 142 142 117
Deferred Charges NA 632 564 533 495
Intangibles NA 279 285 291 296
Deposits & Other Assets NA 54 83 33 22
Total Assets NA 6,782 6,388 6,208 5,798
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA 0 0 0
Accounts Payable NA 110 139 156 56
Current Portion Long-Term Debt NA NA 0 0 0
Current Portion Capital Leases NA 3 3 3 3
Accrued Expenses NA 1,127 982 960 947
Income Taxes Payable NA NA 0 0 0
Other Current Liabilities NA NA 0 0 0
Total Current Liabilities NA 1,240 1,125 1,119 1,006
Mortgages NA NA 0 0 0
Deferred Taxes/Income NA NA 0 0 0
Convertible Debt NA NA 0 0 0
Long-Term Debt NA NA 0 0 0
Non-Current Capital Leases NA 29 29 29 30
Other Non-Current Liabilities NA 303 319 299
Minority Interest (Liabilities) NA NA 0 0 0
Total Liabilities NA 1,592 1,457 1,468 1,335
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 5,016 4,949 4,926 4,857
Retained Earnings NA 160 -41 -212 -416
Other Equity NA 13 23 27 21
Treasury Stock NA NA 0 0 0
Total Shareholder's Equity NA 5,190 4,931 4,741 4,463
Total Liabilities & Shareholder's Equity NA 6,782 6,388 6,208 5,798
Total Common Equity 0 105,189 4,931 4,741 4,463
Shares Outstanding 224.50 224.10 224.00 223.00 223.00
Book Value Per Share 0.00 469.38 22.02 21.26 20.01